For patients with COPD, budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol.

A Minnesota mom will spend less than four years in prison after pleading guilty to manslaughter after she and her husband ...

A mom in Minnesota is heading to prison for causing the death of her daughter after she refused to let the parents of one of ...

Asthma is a disease of the lungs that affects people of all ages and both sexes. About 1 in 13 people in the United States ...

The study highlights T2-low and T17-high asthma endotypes in minoritized youths, offering insights for precision medicine and ...

A study compares budesonide-glycopyrrolate-formoterol and fluticasone-umeclidinium-vilanterol, revealing insights on COPD ...

The result was a device, using gaming-style software, that could show young asthma patients how to use their inhalers more effectively. Prof Aslam, who works at the University of Manchester ...

Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today. A 19-year-old who caused the death of three teenagers by ...

A device costing just pennies, based on an idea by a University of Manchester Professor to help his son use an inhaler, could be a gamechanger for asthma patients. The impressive results are from ...

Mannkind Corporation expects to submit a request for a supplemental new drug application meeting to the US Food and Drug Administration for its inhaled ... patients with asthma and chronic ...

Dec. 16, 2024 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products ... observed in Afrezza-treated ...

“Afrezza is a rapid-acting insulin delivered through an inhaler as compared to current insulins which are given as injections. Taken at the beginning of a meal, Afrezza dissolves rapidly upon ...